Delivery Order SPE2DB20D9127-SPE2DB25FPRR4
Award Date 9/26/25
Potential Completion Date 10/20/25
Potential Value $15K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $37,659.45 to DMS Pharmaceutical Group Inc. for EXPAREL 266 mg/20 mL vials. The order was issued on September 11, 2025, with an ultimate completion date of October 2, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $4,521.66 to DMS Pharmaceutical Group Inc. for the supply of EXPAREL 133mg/10ml (10 units). The award was issued on August 7, 2025, with an ultimate completion date of August 26, 2025. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery from its Park Ridge location. This delivery order carries no set-aside designation...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $17,574.41 to DMS Pharmaceutical Group Inc. on August 11, 2025, for the supply of EXPAREL 266 mg/20 mL vials. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this contract at its Park Ridge facility with an ultimate completion date of September 2, 2025. This delivery order was issued without a set-aside designation, allowing...
- The Defense Logistics Agency (DLA), operating under the Department of Defense, awarded a delivery order valued at $35,148.82 to DMS Pharmaceutical Group Inc. on September 23, 2025, for the supply of EXPAREL 266 mg/20 ml vials. This firm fixed-price delivery order is expected to be completed by October 15, 2025, with fulfillment from the vendor's location in Park Ridge, Illinois. The contract does not utilize a set-aside designation, allowing DMS Pharmaceutical Group to compete on a competitive...
- The Defense Logistics Agency awarded a $19,662.12 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 26, 2025, for the supply of EXPAREL 266 mg/20 ml vials. The order, with an ultimate completion date of October 20, 2025, represents a continuation of the agency's pharmaceutical supply chain operations. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation, competing...
- The Defense Logistics Agency awarded a $15,063.78 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on June 18, 2025, for the supply of EXPAREL 266 mg/20 mL vials. EXPAREL is a liposomal bupivacaine local anesthetic used for infiltration and nerve block procedures in surgical settings. The delivery order, which carries an ultimate completion date of July 11, 2025, was issued without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $10,042.52 to DMS Pharmaceutical Group Inc. on September 11, 2025, for the supply of EXPAREL 266 mg/20 mL vials. EXPAREL is a liposomal bupivacaine formulation used for surgical site infiltration and nerve block anesthesia. This firm fixed-price delivery order, with an ultimate completion date of October 2, 2025, will be delivered to Park Ridge, Illinois. The award carries no set-aside designation, allowing DMS Pharmaceutical...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $12,553.15 to DMS Pharmaceutical Group Inc. for the supply of EXPAREL (liposomal bupivacaine) 266 mg/20 ml vials. This award, issued on September 23, 2025, with an ultimate completion date of October 15, 2025, represents a single delivery order without set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $7,531.89 to DMS Pharmaceutical Group Inc. for the supply of EXPAREL 266 mg/20 mL vials. The award, issued on July 31, 2025, with an ultimate completion date of August 21, 2025, does not utilize a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform this delivery order at its Park Ridge location. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $9,043.32 to DMS Pharmaceutical Group Inc. on September 26, 2025, for the supply of EXPAREL 133 mg/10 ml vials. The contract utilizes firm fixed-price pricing with an ultimate completion date of October 20, 2025, and is performed at the vendor's location in Park Ridge, Illinois. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA under the SPE2DB program, a $500 million...